SmartPharma Group, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 372,814 |
| 255,352 |
| 22,583 |
| 19,191 |
| 13,145 |
| 9.02 |
| 5.15 |
| 43,541 |
| 32,142 |
| 1,487 |
| 74,196 |
| 0.11 |
| 0.74 |
| - |
| - |
| 6.06 |
| 22,583 |
| 2023 |
|---|
| 446,037 |
| 437,291 |
| 26,112 |
| 22,195 |
| 21,760 |
| 17.25 |
| 4.98 |
| 65,736 |
| 222,515 |
| 29,388 |
| 258,588 |
| 0.14 |
| 3.38 |
| - |
| - |
| 8.48 |
| 37,815 |
| 2024 |
|---|
| 858,736 |
| 727,742 |
| 321,651 |
| 273,400 |
| 231,695 |
| 42.52 |
| 31.84 |
| 339,136 |
| 82,909 |
| 273,657 |
| 148,388 |
| 0.10 |
| 0.24 |
| - |
| - |
| 39.04 |
| 335,293 |
| 2024 |
|---|
| 858,736 |
| 727,742 |
| 321,651 |
| 273,400 |
| 231,695 |
| 42.52 |
| 31.84 |
| 339,136 |
| 82,909 |
| 273,657 |
| 148,388 |
| 0.10 |
| 0.24 |
| - |
| - |
| 39.04 |
| 335,293 |
Turnover (€)
2024
Turnover (€)
858,736 €93 % *
Sales per employee (€)
727,742 €66 % *
Profit before tax (€)
321,651 €1,132 % *
Net Profit (€)
273,400 €1,132 % *
Profit per employee (€)
231,695 €965 % *
Total profitability (%)
42.52 %146.49 % *
Net profitability (%)
31.84 %539.36 % *
Equity (€)
339,136 €416 % *
Amounts Payable And Liabilities (€)
82,909 €-63 % *
Non-current Assets (€)
273,657 €831 % *
CurrentAssets (€)
148,388 €-43 % *
Working capital requirement
0.10 -28.57 % *
Debt-to-equity ratio
0.24 -92.90 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
39.04 %360.38 % *
EBIT (€)
335,293 €787 % *
